£6.5m investment to tackle Alzheimer’s disease

A new biotech company, AstronauTx, which builds on UCL research and will develop medicines that potentially limit the damage Alzheimer’s causes has received a £6.5 million investment.

Read: Evening Standard, More: UCL News